Brief: Compugroup Medical FY Free Cash Flow EUR 113 Million
07/02/2024 06:04
Feb 07 (Reuters) - Compugroup Medical FY organic growth 4.3%. * FY adjusted EPS EUR 2.06 * FY adjusted EBITDA EUR 265 million vs. IBES estimate EUR 268.2 million * FY revenue EUR 1,190 million vs. IBES estimate EUR 1,189 million * outlook FY adjusted EBITDA EUR 270-310 million
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share